Association of annexin A2 with cancer development (Review)

Xiao-Heng Xu1, Wei Pan2, Li-Hua Kang1

  • 1Cancer Center, The First Hospital of Jilin University, Changchun, Jilin, P.R. China.

Oncology Reports
|March 12, 2015
PubMed

Insights

Annexin A2 (ANXA2) is a protein involved in various cellular processes. This review explores its role in cancer progression, highlighting its potential as a therapeutic target.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • Annexin A2 (ANXA2) is a calcium-dependent phospholipid-binding protein found in various cellular compartments.
  • ANXA2 is a pleiotropic protein influencing numerous molecular and cellular functions.
  • Aberrant ANXA2 expression is associated with diseases like cancer, autoimmune disorders, and inflammation.

Purpose of the Study:

  • To systematically review the multifaceted roles of Annexin A2 in tumor progression.
  • To elucidate the mechanisms underlying ANXA2's involvement in cancer development.
  • To identify ANXA2 as a potential therapeutic target for cancer treatment.

Main Methods:

  • Systematic literature review of studies on Annexin A2 and cancer.
  • Analysis of ANXA2's effects on tumor cell adhesion, proliferation, apoptosis, invasion, and metastasis.
  • Examination of ANXA2's role in tumor neovascularization.

Main Results:

  • ANXA2 is aberrantly expressed across a wide spectrum of cancers.
  • ANXA2 significantly impacts key hallmarks of cancer, including proliferation, invasion, and metastasis.
  • ANXA2 influences tumor angiogenesis through various mechanisms.

Conclusions:

  • Understanding the complex mechanisms of ANXA2 in cancer is crucial for developing effective therapies.
  • ANXA2 represents a promising molecular target for novel cancer treatment strategies.
  • Further research into ANXA2's functions may unlock new avenues for cancer therapy.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...